Chemoinformaics analysis of 1-Hydroxyheptan-2-one
| Molecular Weight | 130.187 | nRot | 5 |
| Heavy Atom Molecular Weight | 116.075 | nRig | 1 |
| Exact Molecular Weight | 130.099 | nRing | 0 |
| Solubility: LogS | -0.796 | nHRing | 0 |
| Solubility: LogP | 1.234 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 22.6291 |
| nHD | 1 | BPOL | 14.9129 |
| QED | 0.566 |
| Synth | 2.033 |
| Natural Product Likeliness | 1.531 |
| NR-PPAR-gamma | 0.012 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.015 |
| Pgp-sub | 0.046 |
| HIA | 0.007 |
| CACO-2 | -4.266 |
| MDCK | 0.0000283 |
| BBB | 0.965 |
| PPB | 0.339591 |
| VDSS | 0.756 |
| FU | 0.702338 |
| CYP1A2-inh | 0.181 |
| CYP1A2-sub | 0.605 |
| CYP2c19-inh | 0.032 |
| CYP2c19-sub | 0.299 |
| CYP2c9-inh | 0.015 |
| CYP2c9-sub | 0.261 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.208 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.139 |
| CL | 7.237 |
| T12 | 0.942 |
| hERG | 0.032 |
| Ames | 0.165 |
| ROA | 0.18 |
| SkinSen | 0.696 |
| Carcinogencity | 0.045 |
| EI | 0.992 |
| Respiratory | 0.564 |
| NR-Aromatase | 0.015 |
| Antiviral | No |
| Prediction | 0.951564 |